Want to join the conversation?
$MDT has continued to invest in new technologies to drive future growth. R&D expense rose $193MM to $558MM in 1Q16 as $MDT continues to innovate and develop new value-based offerings for the market. The medical device maker expects R&D expense as a percentage of net sales to continue to be 7-8% in FY16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?